Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Sealzad
    Junior Member
    • Feb 2018
    • 6

    #1

    Advice on using sailfish-cir's output to justify circular RNA (circRNA)

    Hi,

    I have a problem trying to focus on a specific gene to study for circRNA.

    In my work, I have both control and diseased condition. I generated circRNA from circular RNA identifier (CIRI2) as well as "quantified" it with sailfish-cir for each condition. From my understanding, CIRI2 presents results based on gene level (Ensembl gene ID), and feature them in terms of coordinates. Sailfish-cir presents results based on transcript level. So their IDs are Ensembl transcript's. But a gene ID can have multiple transcript ID. So how does one consider which transcript to focus on? Rather, how does one make the comparison, or focus on which genes?

    Another question is how does one interpret the TPM value presented in sailfish-cir? Does it mean a proportion of both circRNA and linear fragments per million transcripts? So if the disease has like a value of 5 for TPM and the control has 2, what does it really mean? How does one say it in layman terms?

    Thank you.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...